Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations

BACKGROUND: Coronavirus disease 2019 (COVID‐19) convalescent individuals carry antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that, through a plasma donation, can be used as a potential therapeutic either in direct transfusion or for the manufacture of hyperimmune gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Karbiener, Michael, Farcet, Maria R., Ilk, Reinhard, Schreiner, Jessica, Lenart, James, Powers, Nicholas, Stewart, Joseph M., Tallman, Hema, Kreil, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Donor Infectious Disease Testing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013317/
https://www.ncbi.nlm.nih.gov/pubmed/33615484
http://dx.doi.org/10.1111/trf.16291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013317/
https://www.ncbi.nlm.nih.gov/pubmed/33615484
http://dx.doi.org/10.1111/trf.16291

Ejemplares similares